Answers are grounded in this paper and cite their sources.
Emerging evidence suggests that the oral microbiome plays a pivotal role not only in maintaining oral health but also in the etiology and progression of a wide range of systemic disorders. This review presents findings from recent literature examining the correlation between oral microbial dysbiosis and various systemic diseases—including cancer, obesity, cleft lip and palate (CLP), pulmonary conditions such as pneumonia and COPD, cardiovascular diseases, and neurogenic disorders like Parkinson’s disease (PD). The mechanisms linking oral microbiota to systemic pathologies primarily involve chronic inflammation, immune dysregulation, metabolic disruption, and microbial translocation. In cancer and cardiovascular diseases, key oral pathogens have been implicated in tumorigenesis and atherogenesis, respectively. In obesity and metabolic syndrome, they contribute to systemic inflammation and insulin resistance. In CLP, impaired microbial balance worsens healing outcomes, while in pulmonary diseases, aspirated oral bacteria act as reservoirs for respiratory pathogens. In PD, oral dysbiosis may exacerbate neuroinflammation and increase the risk of aspiration pneumonia. These associations underscore the diagnostic and therapeutic potential of oral microbiota, positioning them as viable targets for early intervention, risk stratification, and management of systemic conditions.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: